Dietary supplements for established atopic eczema.

BACKGROUND Many people with atopic eczema are reluctant to use the most commonly recommended treatments because they fear the long-term health effects. As a result, many turn to dietary supplements as a possible treatment approach, often with the belief that some essential ingredient is 'missing' in their diet. Various supplements have been proposed, but it is unclear whether any of these interventions are effective. OBJECTIVES To evaluate dietary supplements for treating established atopic eczema/dermatitis.Evening primrose oil, borage oil, and probiotics are covered in other Cochrane reviews. SEARCH METHODS We searched the following databases up to July 2010: the Cochrane Skin Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE (from 2005), EMBASE (from 2007), PsycINFO (from 1806), AMED (from 1985), LILACS (from 1982), ISI Web of Science, GREAT (Global Resource of EczemA Trials) database, and reference lists of articles. We searched ongoing trials registers up to April 2011. SELECTION CRITERIA Randomised controlled trials (RCTs) of dietary supplements for the treatment of those with established atopic eczema/dermatitis. DATA COLLECTION AND ANALYSIS Two authors independently screened the titles and abstracts, read the full text of the publications, extracted data, and assessed the risk of bias. MAIN RESULTS We included 11 studies with a total of 596 participants. Two studies assessed fish oil versus olive oil or corn oil placebo. The following were all looked at in single studies: oral zinc sulphate compared to placebo, selenium versus selenium plus vitamin E versus placebo, vitamin D versus placebo, vitamin D versus vitamin E versus vitamins D plus vitamin E together versus placebo, pyridoxine versus placebo, sea buckthorn seed oil versus sea buckthorn pulp oil versus placebo, hempseed oil versus placebo, sunflower oil (linoleic acid) versus fish oil versus placebo, and DHA versus control (saturated fatty acids of the same energy value). Two small studies on fish oil suggest a possible modest benefit, but many outcomes were explored. A convincingly positive result from a much larger study with a publicly-registered protocol is needed before clinical practice can be influenced. AUTHORS' CONCLUSIONS There is no convincing evidence of the benefit of dietary supplements in eczema, and they cannot be recommended for the public or for clinical practice at present. Whilst some may argue that at least supplements do not do any harm, high doses of vitamin D may give rise to serious medical problems, and the cost of long-term supplements may also mount up.

[1]  M. Djalali,et al.  Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis , 2011, The Journal of dermatological treatment.

[2]  H. Williams,et al.  Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. , 2011, The Journal of investigative dermatology.

[3]  S. Sasaki,et al.  Maternal B vitamin intake during pregnancy and wheeze and eczema in Japanese infants aged 16–24 months: The Osaka Maternal and Child Health Study , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[4]  H. Williams,et al.  Harmonising Outcome Measures for Eczema (HOME).Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany , 2010, The British journal of dermatology.

[5]  D. Leung,et al.  Vitamin D in atopic dermatitis, asthma and allergic diseases. , 2010, Immunology and allergy clinics of North America.

[6]  H. Williams,et al.  Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. , 2009, The Journal of allergy and clinical immunology.

[7]  S. Sasaki,et al.  Dairy food, calcium and vitamin D intake in pregnancy, and wheeze and eczema in infants , 2009, European Respiratory Journal.

[8]  Aziz Sheikh,et al.  Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis , 2009, BMJ : British Medical Journal.

[9]  J. Leonardi-Bee,et al.  Probiotics for treating eczema. , 2008, The Cochrane database of systematic reviews.

[10]  R. Gallo,et al.  Administration of oral vitamin D induces cathelicidin production in atopic individuals. , 2008, The Journal of allergy and clinical immunology.

[11]  C. Camargo,et al.  Randomized controlled trial of vitamin D supplementation for winter‐related atopic dermatitis in Boston: a pilot study , 2008, The British journal of dermatology.

[12]  H. R. Anderson,et al.  Is eczema really on the increase worldwide? , 2008, The Journal of allergy and clinical immunology.

[13]  M. Worm,et al.  Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double‐blind, controlled trial , 2008, The British journal of dermatology.

[14]  M. Moore,et al.  Sleep disruptions in parents of children and adolescents with chronic illnesses: prevalence, causes, and consequences. , 2007, Journal of pediatric psychology.

[15]  H. Williams,et al.  What are the best outcome measurements for atopic eczema? A systematic review. , 2007, The Journal of allergy and clinical immunology.

[16]  D. Strachan,et al.  Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys , 2006, The Lancet.

[17]  Bondevik Bjørn Eriksen,et al.  Open trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis , 2006, The Journal of dermatological treatment.

[18]  U. Schwab,et al.  Efficacy of dietary hempseed oil in patients with atopic dermatitis , 2005, The Journal of dermatological treatment.

[19]  H. Williams,et al.  How atopic is atopic dermatitis? , 2004, The Journal of allergy and clinical immunology.

[20]  Thomas Bieber,et al.  Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. , 2004, The Journal of allergy and clinical immunology.

[21]  H. Williams,et al.  Evening primrose oil for atopic dermatitis , 2003, BMJ : British Medical Journal.

[22]  E. Ernst,et al.  Oral evening primrose oil and borage oil for atopic eczema , 2003 .

[23]  W. Cookson Genetics and genomics of asthma and allergic diseases , 2002, Immunological reviews.

[24]  F. Rutten,et al.  The cost of atopic dermatitis in the Netherlands: an international comparison , 2002, The British journal of dermatology.

[25]  M. Kalliomäki,et al.  Pandemic of atopic diseases--a lack of microbial exposure in early infancy? , 2002, Current drug targets. Infectious disorders.

[26]  H. P. Bever Early events in atopy , 2002, European Journal of Pediatrics.

[27]  W. Seeger,et al.  A double-blind, randomized, placebo-controlled trial of n-3 versus n-6 fatty acid-based lipid infusion in atopic dermatitis. , 2002, JPEN. Journal of parenteral and enteral nutrition.

[28]  U. Schneyer,et al.  Delay of growth and development in children with bronchial asthma, atopic dermatitis and allergic rhinitis. , 2002, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[29]  M. Rademaker,et al.  Pharmacoeconomics of drug therapy for atopic dermatitis , 2002, Expert opinion on pharmacotherapy.

[30]  K. thestrup-pedersen Treatment principles of atopic dermatitis , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[31]  J. Bousquet,et al.  A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force , 2001, Allergy.

[32]  D. Altman,et al.  Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.

[33]  Fendrick Am,et al.  Allergen-induced inflammation and the role of immunoglobulin E (IgE). , 2001 .

[34]  Å. Svensson,et al.  Clinical features of atopic dermatitis at two years of age: a prospective, population-based case-control study. , 2001, Acta dermato-venereologica.

[35]  R. Polosa The interaction between particulate air pollution and allergens in enhancing allergic and airway responses , 2001, Current allergy and asthma reports.

[36]  D. Leung,et al.  Allergen sensitization through the skin induces systemic allergic responses. , 2000, The Journal of allergy and clinical immunology.

[37]  J. Popay,et al.  The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research , 2000, Journal of epidemiology and community health.

[38]  J. Katajisto,et al.  Effect of dietary supplementation with sea buckthorn (Hippophaë rhamnoides) seed and pulp oils on the fatty acid composition of skin glycerophospholipids of patients with atopic dermatitis. , 2000, The Journal of nutritional biochemistry.

[39]  H. Williams,et al.  Outcome measures of disease severity in atopic eczema. , 2000, Archives of dermatology.

[40]  H. Williams,et al.  Topical corticosteroid phobia in patients with atopic eczema , 2000, The British journal of dermatology.

[41]  H. Williams,et al.  Atopic dermatitis: The natural history of atopic dermatitis , 2000 .

[42]  J. Katajisto,et al.  Effects of dietary supplementation with sea buckthorn (Hippophaë rhamnoides) seed and pulp oils on atopic dermatitis. , 1999, The Journal of nutritional biochemistry.

[43]  Allen,et al.  Severity distribution of atopic dermatitis in the community and its relationship to secondary referral , 1998, The British journal of dermatology.

[44]  M. Chren,et al.  Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. , 1997, Archives of dermatology.

[45]  G. Varigos,et al.  Atopic eczema: its impact on the family and financial cost , 1997, Archives of disease in childhood.

[46]  A. Finlay Measurement of disease activity and outcome in atopic dermatitis , 1996, The British journal of dermatology.

[47]  R. Prescott,et al.  The cost of atopic eczema , 1996, The British journal of dermatology.

[48]  S. Hollis,et al.  Pyridoxine in atopic dermatitis , 1995, The British journal of dermatology.

[49]  H. Williams,et al.  Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London. , 1995, BMJ.

[50]  C. Drevon,et al.  Dietary supplementation with very long‐chain n‐3 fatty acids in patients with atopic dermatitis. A double‐blind, multicentre study , 1994, The British journal of dermatology.

[51]  A. Czeizel,et al.  Postnatal somatic and mental development after periconceptional multivitamin supplementation. , 1994, Archives of disease in childhood.

[52]  H. Williams,et al.  Is the prevalence of atopic dermatitis increasing? , 1992, Clinical and experimental dermatology.

[53]  T. David,et al.  Failure of oral zinc supplementation in atopic eczema. , 1991, European journal of clinical nutrition.

[54]  C. Drevon,et al.  Effect of n‐3 fatty acid supplement to patients with atopic dermatitis , 1989, Journal of internal medicine. Supplement.

[55]  B. Clayton,et al.  The Effect of Supplementation with Selenium and Vitamin E in Psoriasis , 1989, Annals of clinical biochemistry.

[56]  D. Sackett,et al.  Controversy in counting and attributing events in clinical trials. , 1979, The New England journal of medicine.

[57]  A. Kemp Cost of Illness of Atopic Dermatitis in Children , 2012, PharmacoEconomics.

[58]  G. Schwalfenberg,et al.  A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. , 2011, Molecular nutrition & food research.

[59]  E. Simpson,et al.  Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. , 2011, The Journal of investigative dermatology.

[60]  K. Kaulback,et al.  The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic Review , 2008, Pediatric dermatology.

[61]  E. Ernst,et al.  Complementary/Alternative Medicine in Dermatology , 2002, American journal of clinical dermatology.

[62]  H. Williams,et al.  Systematic review of treatments for atopic eczema. , 2000, Health technology assessment.

[63]  D. Strachan,et al.  Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. , 1999, The Journal of allergy and clinical immunology.

[64]  C. Wale,et al.  Effects of linoleic acid supplements on atopic dermatitis. , 1997, Advances in experimental medicine and biology.

[65]  B. Clayton,et al.  The effect on atopic dermatitis of supplementation with selenium and vitamin E. , 1989, Acta dermato-venereologica.